Back to Search
THOMAS LYNCH, M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1801144126Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Novel agents in the treatment of lung cancer: Fourth Cambridge Conference.
PMID 17671145·Clin Cancer Res·2007
7-preclinical
p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma.
PMID 19302219·Dis Esophagus·2010
8-other
(18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT.
PMID 19665324·Int J Radiat Oncol Biol Phys·2010
8-other
Multiple risk factors related to familial predisposition to anterior cruciate ligament injury: fraternal twin sisters with anterior cruciate ligament ruptures.
PMID 19158132·Br J Sports Med·2010
5-case
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes.
PMID 19620936·Pharmacogenet Genomics·2009
8-other
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.
PMID 19633475·J Thorac Oncol·2009
3-trial
Epidermal growth factor receptor tyrosine kinase inhibitors and depression.
PMID 19597022·J Clin Oncol·2009
8-other
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
PMID 19667264·J Clin Oncol·2009
8-other
p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.
PMID 19383811·Clin Cancer Res·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3490 BALLYBRIDGE CIR APT 201
BONITA SPRINGS, FL 34134 - Phone
- (865) 567-9877
Quick Facts
- NPI
- 1801144126
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile